Oleksandra Alchuk

Oleksandra Alchuk

Auto-generated profile, based on publicly available information

Oleksandra Alchuk

National Pirogov Memorial Medical University, Vinnytsya

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Reports of Vinnytsia National Medical University
Verified
Journal Article
Open access
PDF file
HKH. I. Kramar
H. I. Kramar
OKO. V. Kryvoviaz
O. V. Kryvoviaz
YTY. O. Tomashevska
Y. O. Tomashevska
OTO. Iu. Toziuk
O. Iu. Toziuk
VKV. V. Kudria
V. V. Kudria
OAO. I. Alchuk
O. I. Alchuk
Annotation. The development of protein products has a number of difficulties and uncertainties regarding the use of excipients due to the high instability of the active pharmaceutical ingredient. The aim of the study was to analyze the nomenclature of excipients in original medicines of biological origin and evidence-based information on general trends in their use in protein products. Based on the content analysis of scientific sources of pharmaceutical information using data from PubMed, Elsevier and Compendium scientific databases, the State Register of Medicines of Ukraine, the most common excipients in biological medicines available on the Ukrainian market were identified. It was found that the main categories of substances were: buffering agents, pH regulators, surfactants and lyoprotectants that ensure the stability of biological drugs, which are mostly represented by parenteral dosage forms. In these drugs, sodium phosphate, sodium hydroxide, hydrochloric acid are often used to stabilize pH, and histidine is used in monoclonal antibodies. To protect protein compositions from mechanical stresses, surfactants such as polysorbate 80 and polysorbate 20 were used in a larger percentage of preparations. Sugars such as sucrose, trehalose, lactose, sorbitol, mannitol, and glycine played an important role in protecting the protein from destabilizing conditions during the lyophilization process. Excipients that are typical only for protein products were found. In particular, phenol in polypeptide hormone formulations and methacresol in cytokine and growth factor formulations as antimicrobial preservatives; zinc and protamine sulfate in insulin formulations as stabilizers. Albumin as a stabilizer and solubilizer is present in preparations with cytokines and growth factors, toxins and some enzymes. Excipients, in addition to ensuring stability during transportation and use of biological drugs in various environmental conditions, affect their safety profiles and therefore require serious clinical consideration to improve the safety of these drugs.

1 January 2024 in Fitoterapia
Verified
Journal Article
Closed access
LBLiliia Budniak
Liliia Budniak
LSLiudmyla Slobodianiuk
Liudmyla Slobodianiuk
RKRoman Kotsyuba
Roman Kotsyuba
OAOleksandra Alchuk
Oleksandra Alchuk
OSOlena Shkondina
Olena Shkondina
SCSvitlana Chernetska
Svitlana Chernetska

1 January 2024 in Fitoterapia
Verified
Journal Article
Closed access
LBLiliia Budniak
Liliia Budniak
MSMarina Sytnyk
Marina Sytnyk
LSLiudmyla Slobodianiuk
Liudmyla Slobodianiuk
SMSvitlana Marchyshyn
Svitlana Marchyshyn
OAOleksandra Alchuk
Oleksandra Alchuk
ITIhor Tverdokhlib
Ihor Tverdokhlib

28 February 2025 in Медична освіта
Verified
Journal Article
Open access
ОАО. І. Альчук
О. І. Альчук
ОШО. В. Шевчук
О. В. Шевчук
НВН. І. Волощук
Н. І. Волощук
Анотація. Глобальна діджиталізація, штучний інтелект, швидка еволюція технології передачі інформації, з одного боку, COVID-19 та велика повномасштабної агресія росії у 2022 р. – з іншого, поставили перед викладацьким складом ЗВО, зокрема перед колективом кафедри фармакології ВНМУ ім. М.І. Пирогова низку важливих завдань та проблем, які потрібно було вирішувати не лише ефективно, а й швидко. У роботі висвітлено наш досвід застосування сучасних дистанційних комунікаційно-цифрових технологій у поєднанні з новими методиками аудиторних занять. Описано методику дистанційних занять, які проводилися за допомогою сервісу MS Teams, що об'єднала всі навчальні ресурси нашого університету та дає змогу відстежити весь алгоритм роботи студента. Викладено особливості проведення проміжних заліків та екзамену в умовах дистанційного навчання. Проведений нами аналіз проблем, що виникали під час дистанційного навчання, з одного боку, та розуміння абсолютної невід’ємності online-інструментів у житті суспільства – з іншого, дали змогу випробувати та втілити в життя змішаний формат (blendetlearning) ведення практичних занять з акцентом на комунікативний та персоніфікований, особистісний підхід до студентів. Маючи в арсеналі багато цікавих, дієвих інформаційно-комунікативних технологій викладання, нашим першочерговим завданням стало привернути увагу та зацікавленість студентів до offline-занять. Ми прагнули підвищити мотивацію студентів і водночас максимально полегшити сам процес засвоєння вкрай складного предмету. Завдячуючи описаним у статті методикам викладачам кафедри вдалося привернути увагу студентів до аудиторного навчання, підвищити їхній інтерес та бажання вчитися, полегшити вивчення фармакології та максимально наблизити їх до практичної медицини. Підтвердженням цього є надзвичайно великий інтерес наших студентів до олімпіади з фармакології, зацікавленість у роботі наукового гуртка та чудово виконані студентські наукові роботи на щорічних студентських наукових конференціях.

26 February 2025 in Farmatsevtychnyi zhurnal
Verified
Journal Article
Open access
PDF file
ГКГ. І. Крамар
Г. І. Крамар
ОМО. В. Макаренко
О. В. Макаренко
ОАО. І. Альчук
О. І. Альчук
HKH. І. Kramar
H. І. Kramar
Rapid urbanization, mechanization and automation of labor activity and everyday life in recent decades has led to the spread of physical inactivity and, as a result, to the development of venous syndromes in the younger population of the world. The pharmacological effect of phlebotonics is aimed at normalizing vascular wall permeability, improving the rheological properties of blood and eliminating early symptoms of varicose veins. The purpose of the study was to examine the range of medicines and supplements used for the symptomatic treatment of veno-lymphatic insufficiency in the Ukrainian market. The study of the range of medicines for the symptomatic treatment of veno-lymphatic insufficiency in Ukraine was carried out using a content analysis of the State Register of Drugs. The following scheme was used to study the set of drugs and dietary supplements with venotonic effect: analysis of drugs by ATX classification, dosage form, composition, country and manufacturer. The main research methods used were marketing, statistical and graphical. The results of the analysis of ATC-group C05 «Angioprotectors» showed that 35 drugs of various dosage forms from eight countries with venotonic effect were registered in the pharmaceutical market of Ukraine. The largest number of trade names is registered in the group of bioflavanoids, in particular Troxerutin C05C A04 (22.85%), Diosmin, combinations C05C A53 (17.14%), Escin, combinations C05C X51 (17.14%). The group Heparin or heparinoids for topical use C05B A03 (60%) can be separately distinguished, which are also used in the complex treatment of varicose veins. In the domestic market, the share of Ukrainian-made phlebotonics prevails (51.42%), represented by tablets and soft dosage forms (22.85%), capsules and oral drops (2.85%). German-made drugs are represented by oral drops (8.57%), tablets and capsules (2.85% each), Bulgarian drugs are topical products, including gels (8.57%) and tablets, and French drugs are represented by capsules only (8.57%). The pharmaceutical market of Ukraine has about 26. The supplements are represented by flavonoid fractions of diosmin and hesperidin (39.8%), diosmin (7.14%), combined supplements containing plant extracts, quercetin, ascorbic acid, sodium heparin, troxerutin, rutin, in the form of tablets and capsules of Ukrainian and foreign production.

27 February 2023 in Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
Verified
Journal Article
Open access
AKA. O. Kushta
A. O. Kushta
DPD. O. Perminov
D. O. Perminov
NVN. I. Voloshchuk
N. I. Voloshchuk
OAO. I. Alchuk
O. I. Alchuk
The purpose of the study was to experimentally substantiate the feasibility of arginine glutamate using, for the correction of reparative disorders in rats with partial food deprivation. Materials and methods. The work uses such research methods as modeling of food deprivation according to a patented method, modeling a wound defect of rat’s skin, evaluating the healing of wound defects by taking pictures with a camera with a resolution of 12 megapixels and subsequent processing with a special computer program Universal desktop ruler, version 11, for determining the area, determination of integral indicators of total protein, albumin, glucose, urea in blood serum of rats by spectrophotometric methods (“Filicit-diagnostics”). Statistical processing of the obtained results was carried out using non-parametric methods of analysis (MANOVA-test) using Statistica 6.0 software. Differences at p<0.05 were considered significant. Results and discussion. As a result of the food crisis, the share of hungry people in the world increases every year, and in 2022 it reached 9.8% of the world population. Starvation directly and indirectly prevents the successful healing of wounds, which is also complicated by impaired liver function. Partial food deprivation was accompanied by a violation of metabolic processes in the body of rats: a decrease in body weight (about 30%, p<0.05), a probable decrease in the content of glucose (by 24.5%), total protein and albumin (by 16.1 and 26.2%, respectively, p<0.05) with a simultaneous increase in the content of indicators of nitrogen metabolism in the blood. In addition, nutritionally deficient animals had a 4.7-day delay in wound healing compared to the control group. The use of arginine glutamate, in food-deprived rats caused a reduction in the wound skin defect and was accompanied by a partial normalization of metabolic processes: the total protein content and the amount of blood albumin were higher than those in the model pathology group without correction by 10.2 and 12.9%, respectively (p<0.05), the glucose content increased (+12.2%); simultaneously blood urea content was lower by 25.2% (p<0.05). Conclusion. The obtained data are an experimental basis for further clinical studies of the possibility of practical use of arginine glutamate in the complex treatment of patients with wound processes, especially under conditions of nutritional insufficiency